Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merrem I.V. Shortage Due To Increased Regional Demand, AstraZeneca Says

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA’s website states the antibiotic shortage stems from “manufacturing delays due to bulk drug supply shortages.” The company does not plan to ration shipments to U.S. regions that are not experiencing increased demand.

You may also be interested in...



Merrem I.V. Shortage May Continue Into 2006

Short supply of AstraZeneca's antibiotic is attributed to manufacturing delays and increased demand.

Merrem I.V. Shortage May Continue Into 2006

Short supply of AstraZeneca's antibiotic is attributed to manufacturing delays and increased demand.

Pediatric Studies For AstraZeneca’s Merrem Referred To NIH

The National Institutes of Health is seeking input on a study request for meropenem in children less than three moths old with complicated intra-abdominal infections. The request includes a randomized, active controlled study and a pharmacokinetic study.

Topics

UsernamePublicRestriction

Register

OM006922

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel